Coronavirus disease 2019: A bibliometric analysis and review

European Review for Medical and Pharmacological Sciences

Volumn 24, Issue 6, 2020, Pages 3411-3421

  Lou, J ^a   Tian, S J ^a   Niu, S M ^a   Kang, X Q ^a   Lian, H X ^a   Zhang, L X ^a   Zhang, J J ^a  

^a Beijing Emergency Medical Center   (China)

Author keywords

Corona virus disease 2019; COVID 19; NCP; Novel coronavirus pneumonia; Review

Indexed keywords

ARTICLE; BIBLIOMETRICS; CHINA; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; EPIDEMIC; HUMAN; INCIDENCE; PUBLICATION; THERAPY EFFECT; VIROLOGY; BETACORONAVIRUS; LABORATORY TECHNIQUE; PANDEMIC; VIRUS PNEUMONIA;

BETACORONAVIRUS; BIBLIOMETRICS; CLINICAL LABORATORY TECHNIQUES; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85082974973     PISSN: 11283602     EISSN: 22840729     Source Type: Journal    
DOI: 10.26355/eurrev_202003_20712     Document Type: Article

References (52)

1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020; 395: 497-506.
2. Lu H, Str att on CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 2020: 401-402.
3. WHO. World experts and funders set priorities for COVID-19 research. Mar 07, 2020. https:// www.who.int/docs/default-source/coronaviruse/ situation-reports/20200307-sitrep-47-covid-19. pdf?sfvrsn=27c364a44. Accessed.
4. Stoye E. China coronavirus: how many papers have been published? Nature 2020. doi: 10.1038/ d41586-020-00253-8.
5. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences 2020; 63: 457-460.
6. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect 2020; 9: 221-236.
7. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao G. F, Tan W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727-733.
8. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu W. J, Wang D, Xu W, Holm es E. C, Gao G. F, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, UK) 2020; 395: 565-574.
9. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JI, Xu L, Holm es EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579: 265-269.
10. Nish iura H, Linton NM, Akhm etzh anov AR. Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human transmission. J Clin Med 2020; 9: E488.
11. Bhatt ach ary a M, Sharm a AR, Patr a P, Ghosh P, Sharm a G, Patr a BC, Lee SS, Chakr aborty C. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol 2020. doi: 10.1002/jmv.25736. [Epub ahead of print].
12. Bogoch II , Watts A, Thomas-Bachl i A, Huber C, Kraemer MUG, Khan K. Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med 2020; 27. pii: taaa008.
13. Linton NM, Kobayash i T, Yang Y, Hayash i K, Akhm etzh anov AR, Jung SM, Yuan B, Kinosh ita R, Nish iura H. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med. 2020 Feb 17; 9. pii: E538.
14. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 145-151.
15. Hoehl S, Berger A, Kort enbusch M, Cinatl J, Bojk ova D, Rabenau H, Behr ens P, Ddinghaus BB, Tsch UG , Naujoks F, Neumann P, Sch ork J, Tiarks-Jungk P, Walcz ok A, Eickm ann M, Vehr esch ild Mjgt, Kann G, Wolf T, Gottsch alk R, Ciesek S. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N Engl J Med 2020. doi: 10.1056/ NEJMc2001899. [Epub ahead of print].
16. Back er JA, Klinkenberg D, Wall inga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Eurosurveillance 2020; 25. doi: 10.2807/1560-7917.ES.2020.25.5.2000062.
17. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Li M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JTK, Gao GF, Cowl ing Bj, Yang B, Leung GM, Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020. Doi: 10.1056/NEJMoa2001316.
18. Lei H, Li Y, Xiao S, Lin CH, Norr is SL, Wei D, Hu Z, Ji S. Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: comparative analyses. Indoor Air 2018; 28: 394-403.
19. Ott er JA, Donsk ey C, Yezl i S, Douthw aite S, Gold-enberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 2016; 92: 235-250.
20. Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, Lou Y, Gao D, Yang L, He D, Wang MH. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020; 92: 214-217.
21. Zhao S, Musa SS, Lin Q, Ran J, Yang G, Wang W, Lou Y, Yang L, Gao D, He D, Wang MH. Estimating the unreported number of novel coronavirus (2019-nCoV) cases in China in the first half of January 2020: a data-driven modelling analysis of the early outbreak. J Clin Med 2020; 9. pii: E388.
22. Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL, Zhou P. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9: 386-389.
23. Roth e C, Sch unk M, Sothm ann P, Bretz el G, Froeschl G, Wallr auch C, Zimm er T, Thiel V, Janke C, Guggemos W, Seilm aier M, Drost en C, Vollm ar P, Zwirglm aier K, Zange S, Lfel RW, Hoelsch er M. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020; 382: 970-971.
24. Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, Chen H, Wang D, Liu N, Liu D, Chen G, Zhang Y, Li D, Li J, Lian H, Niu S, Zhang L, Zhang J. Characteristics of COVID-19 infection in Beijing. J Infect 2020. pii: S0163-4453(20)30101-8. doi: 10.1016/j. jinf.2020.02.018. [Epub ahead of print].
25. Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, Zhou L, Liu J. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis 2020. pii: S1473-3099(20)30114-6. doi: 10.1016/S1473-3099(20)30114-6. [Epub ahead of print].
26. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 139-144.
27. Hui DS, Azh ar EI , Madani TA, Ntoumi F, Kock R, Dar O, Ipp olito G, Mch ugh TD, Memish ZA, Drost en C, Zuml a A, Peters en E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020; 91: 264-266.
28. Cheng VCC, Wong SC, To KKW, Ho PL, Yuen KY. Preparedness and proactive infection control measures against the emerging novel coronavirus in China. J Hosp Infect 2020; 104: 254-255.
29. Chen W, Wang Q, Li YQ, Yu HL, Xia YU, Zhang ML, Qin Y, Zhang T, Peng ZB, Zhang RC, Yang XK, Yin WW, An ZJ, Wu D, Yin ZD, Li S, Chen QL, Feng LZ, Li ZJ, Feng ZJ. [Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China]. Zhonghua Yu Fang Yi Xue Za Zhi 2020; 54: 1-6.
30. Chen P, Mao L, Nass is GP, Harm er P, Ainsw orth BE, Li F. Wuhan coronavirus (2019-nCoV): The need to maintain regular physical activity while taking precautions. J Sport Health Sci 2020; 9: 103-104.
31. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med 2020; 9: 19.
32. Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med 2020; 9: E575.
33. Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev 2020. pii: S0887-7963(20)30014-6. doi: 10.1016/j.tmrv.2020.02.003. [Epub ahead of print].
34. Liu S, Yang L, Zhang C, Xiang YT, Liu Z, Hu S, Zhang B. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry 2020. pii: S2215-0366(20)30077-8. doi: 10.1016/S2215-0366(20)30077-8. [Epub ahead of print].
35. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. doi: 10.1056/NEJMoa2002032. [Epub ahead of print].
36. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, UK) 2020; 395: 507-513.
37. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. doi: 10.1001/jama.2020.1585. [Epub ahead of print].
38. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368: m606. doi: 10.1136/bmj.m606. Erratum in: BMJ 2020; 368: m792.
39. Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring. J Med Virol 2020; 92: 464-467.
40. Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, Sun R, Wang Y, Hu B, Chen W, Zhang Y, Wang J, Huang B, Lin Y, Yang J, Cai W, Wang X, Cheng J, Chen Z, Sun K, Pan W, Zhan Z, Chen L, Ye F. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol 2020. Doi: https://doi. org/10.1002/jmv.25727.
41. Xu SP, Kuang D, Hu Y, Liu C, Duan YQ, Wang GP. [Detection of 2019-nCoV in the pathological paraffin embedded tissue]. Zhonghua Bing Li Xue Za Zhi 2020; 49: E004. Doi: 10.3760/ cma.j.cn112151.20200219.00001. [Epub ahead of print].
42. Pan Y, Guan H. Imaging changes in patients with 2019-nCov. Eur Radiol 2020. doi: 10.1007/ s00330-020-06713-z. [Epub ahead of print].
43. Ai T, Yang Z, Hou H, Zhan C, Chen C, LV W, Tao Q, Sun Z, Xia L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020: 200642. doi: 10.1148/radiol.2020200642. [Epub ahead of print].
44. Shi H, Han X, Jiang N, Cao Y, Alw alid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020. pii: S1473-3099(20)30086-4. doi: 10.1016/ S1473-3099(20)30086-4. [Epub ahead of print].
45. Wei J, Xu H, Xiong J, Shen Q, Fan B, Ye C, Dong W, Hu F. 2019 novel coronavirus (COVID-19) pneumonia: serial computed tomography findings. Korean J Radiol 2020. doi: 10.3348/kjr.2020.0112. [Epub ahead of print].
46. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology 2020: 200490. doi: 10.1148/radiol.2020200490. [Epub ahead of print].
47. Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, Hu Q, Xia L. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol 2020. doi: 10.1007/s00330-020-06731-x. [Epub ahead of print].
48. Qin C, Liu F, Yen Tc, Lan X. F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur J Nucl Med Mol Imaging 2020. doi: 10.1007/ s00259-020-04734-w. [Epub ahead of print].
49. Zhou L, Liu HG. [Early detection and disease assessment of patients with novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43: E003. doi: 10.3760/cma.j.issn.1001-0939.2020.0003. [Epub ahead of print].
50. Corm an VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleick er T, Nink S BR, Sch neider J, Schm idt ML, Muld ers DGJC, Haagmans BL, Veer B Van Der, Brink S Van Den, Wijsm an L, Godersk i G, Romett e JL, Ell is J, Zamb on M, Peiris M, Gooss ens H, Reusk en C, Koopm ans MPG, Drost en C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020; 25. doi 10.2807/1560-7917.ES.2020.25.3.2000045.
51. Li H, Wang YM, Xu JY, Cao B. [Potential antiviral therapeutics for 2019 novel coronavirus]. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43: E002. doi: 10.3760/cma.j.issn.1001-0939.2020.0002. [Epub ahead of print].
52. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020; 30: 269-271.